120 related articles for article (PubMed ID: 31296842)
1. Combined treatment with emodin and a telomerase inhibitor induces significant telomere damage/dysfunction and cell death.
Liu R; Liu J; Wang S; Wang Y; Zhang T; Liu Y; Geng X; Wang F
Cell Death Dis; 2019 Jul; 10(7):527. PubMed ID: 31296842
[TBL] [Abstract][Full Text] [Related]
2. Systematic Analysis of Compounds Specifically Targeting Telomeres and Telomerase for Clinical Implications in Cancer Therapy.
Lee HS; Carmena M; Liskovykh M; Peat E; Kim JH; Oshimura M; Masumoto H; Teulade-Fichou MP; Pommier Y; Earnshaw WC; Larionov V; Kouprina N
Cancer Res; 2018 Nov; 78(21):6282-6296. PubMed ID: 30166419
[TBL] [Abstract][Full Text] [Related]
3. Perifosine as a potential novel anti-telomerase therapy.
Holohan B; Hagiopian MM; Lai TP; Huang E; Friedman DR; Wright WE; Shay JW
Oncotarget; 2015 Sep; 6(26):21816-26. PubMed ID: 26307677
[TBL] [Abstract][Full Text] [Related]
4. Telomerase and its potential for therapeutic intervention.
Phatak P; Burger AM
Br J Pharmacol; 2007 Dec; 152(7):1003-11. PubMed ID: 17603541
[TBL] [Abstract][Full Text] [Related]
5. Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease.
Ait-Aissa K; Ebben JD; Kadlec AO; Beyer AM
Pharmacol Res; 2016 Sep; 111():422-433. PubMed ID: 27394166
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of topoisomerase IIA (Top2α) induces telomeric DNA damage and T cell dysfunction during chronic viral infection.
Dang X; Ogbu SC; Zhao J; Nguyen LNT; Cao D; Nguyen LN; Khanal S; Schank M; Thakuri BKC; Wu XY; Morrison ZD; Zhang J; Li Z; El Gazzar M; Ning S; Wang L; Wang Z; Moorman JP; Yao ZQ
Cell Death Dis; 2020 Mar; 11(3):196. PubMed ID: 32193368
[TBL] [Abstract][Full Text] [Related]
7. Pyridostatin analogues promote telomere dysfunction and long-term growth inhibition in human cancer cells.
Müller S; Sanders DA; Di Antonio M; Matsis S; Riou JF; Rodriguez R; Balasubramanian S
Org Biomol Chem; 2012 Aug; 10(32):6537-46. PubMed ID: 22790277
[TBL] [Abstract][Full Text] [Related]
8. Novel quinoxaline analogs as telomeric G-quadruplex ligands exert antitumor effects related to enhanced immunomodulation.
Wang JX; Wang XD; Hu MH
Eur J Med Chem; 2024 May; 274():116536. PubMed ID: 38805936
[TBL] [Abstract][Full Text] [Related]
9. Targeting telomerase reverse transcriptase with the covalent inhibitor NU-1 confers immunogenic radiation sensitization.
Liu Y; Betori RC; Pagacz J; Frost GB; Efimova EV; Wu D; Wolfgeher DJ; Bryan TM; Cohen SB; Scheidt KA; Kron SJ
Cell Chem Biol; 2022 Oct; 29(10):1517-1531.e7. PubMed ID: 36206753
[TBL] [Abstract][Full Text] [Related]
10. Telomerase: a nexus between cancer nanotherapy and circadian rhythm.
Ghosh PK; Rao MJ; Putta CL; Ray S; Rengan AK
Biomater Sci; 2024 Apr; 12(9):2259-2281. PubMed ID: 38596876
[TBL] [Abstract][Full Text] [Related]
11. Terahertz Photons Inhibit Cancer Cells Long Term by Suppressing Nano Telomerase Activity.
Yin J; Wu K; Yu Y; Zhong Y; Song Z; Chang C; Liu G
ACS Nano; 2024 Feb; 18(6):4796-4810. PubMed ID: 38261783
[TBL] [Abstract][Full Text] [Related]
12. pH and redox dual-responsive nanoparticles based on disulfide-containing poly(β-amino ester) for combining chemotherapy and COX-2 inhibitor to overcome drug resistance in breast cancer.
Zhang S; Guo N; Wan G; Zhang T; Li C; Wang Y; Wang Y; Liu Y
J Nanobiotechnology; 2019 Oct; 17(1):109. PubMed ID: 31623608
[TBL] [Abstract][Full Text] [Related]
13. RAD51AP1 Is an Essential Mediator of Alternative Lengthening of Telomeres.
Barroso-González J; García-Expósito L; Hoang SM; Lynskey ML; Roncaioli JL; Ghosh A; Wallace CT; de Vitis M; Modesti M; Bernstein KA; Sarkar SN; Watkins SC; O'Sullivan RJ
Mol Cell; 2019 Oct; 76(1):11-26.e7. PubMed ID: 31400850
[TBL] [Abstract][Full Text] [Related]
14. Folic Acid Supplementation Suppresses Sleep Deprivation-Induced Telomere Dysfunction and Senescence-Associated Secretory Phenotype (SASP).
Zhang X; Wang Y; Zhao R; Hu X; Zhang B; Lv X; Guo Z; Zhang Z; Yuan J; Chu X; Wang F; Li G; Geng X; Liu Y; Sui L; Wang F
Oxid Med Cell Longev; 2019; 2019():4569614. PubMed ID: 31949878
[TBL] [Abstract][Full Text] [Related]
15. Insights into the computer-aided drug design and discovery based on anthraquinone scaffold for cancer treatment: A systematic review.
Chua HM; Moshawih S; Kifli N; Goh HP; Ming LC
PLoS One; 2024; 19(5):e0301396. PubMed ID: 38776291
[TBL] [Abstract][Full Text] [Related]
16. Anticancer action of naturally occurring emodin for the controlling of cervical cancer.
Lande PS; Adhao VS; Ambhore JP; Gaikwad KP; Chandak CS; Joge LP
Explor Target Antitumor Ther; 2023; 4(4):690-698. PubMed ID: 37720346
[TBL] [Abstract][Full Text] [Related]
17. Zeolitic Imidazolate Framework-8 (ZIF-8) as a Drug Delivery Vehicle for the Transport and Release of Telomerase Inhibitor BIBR 1532.
Zhang S; Li J; Yan L; You Y; Zhao F; Cheng J; Yang L; Sun Y; Chang Q; Liu R; Li Y
Nanomaterials (Basel); 2023 May; 13(11):. PubMed ID: 37299682
[TBL] [Abstract][Full Text] [Related]
18. Teloxantron inhibits the processivity of telomerase with preferential DNA damage on telomeres.
Maciejewska N; Olszewski M; Jurasz J; Baginski M; Stasevych M; Zvarych V; Folini M; Zaffaroni N
Cell Death Dis; 2022 Nov; 13(11):1005. PubMed ID: 36437244
[TBL] [Abstract][Full Text] [Related]
19.
Valdiani A; Ofoghi H; Akbarizare M; Talei D
3 Biotech; 2022 Nov; 12(11):319. PubMed ID: 36245958
[TBL] [Abstract][Full Text] [Related]
20. Research Status and Hotspots of Anticancer Natural Products Based on the Patent Literature and Scientific Articles.
Shen J; Li J; Yu P; Du G
Front Pharmacol; 2022; 13():903239. PubMed ID: 35784720
[No Abstract] [Full Text] [Related]
[Next] [New Search]
